Trials / Completed
CompletedNCT00344799
Cytogenetic Study of Ocular Melanoma
Molecular and Cytogenetic Studies of Ocular Melanoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Jonsson Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.
Detailed description
The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogenetic analysis. Our goal is to identify molecular probes that specifically target regions of chromosomes that undergo changes characteristic of metastatic choroidal melanoma.
Conditions
Timeline
- Start date
- 2005-01-08
- Primary completion
- 2020-10-23
- Completion
- 2020-10-23
- First posted
- 2006-06-27
- Last updated
- 2021-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00344799. Inclusion in this directory is not an endorsement.